Cannabis Report
Home > Boards > US Listed > Biotechs >

Hemispherx BioPharma (HEB)

HEB RSS Feed
Add HEB Price Alert      Hide Sticky   Hide Intro
Moderator: borbash
Search This Board: 
Last Post: 9/18/2018 9:41:03 AM - Followers: 236 - Board type: Free - Posts Today: 0

Hemispherx BioPharma (HEB)

Stephen Thorpe has been added as Chief Operating Officer  – HEMISPHERX BIOPHARMA INC 
Mr Thorpe with his background in Building Medical equipment and many years in production automation will be an asset to us.  Factor in his extreme devotion to dogs and  how he cannot be bullied off a life long  meat and potato diet, he has everytrhing you can ask for in a guy to lean on for technical advice and know how. 


WILLIAM CARTER – HEMISPHERX BIOPHARMA INC 

R. WILLIAM CARTER has served as Chief Scientific Officer of Hemispherx Biopharma, Inc., since May 1989, the Chairman of the company's Board of Directors since January 1992, the company's Chief Executive Officer since July 1993, the company's President since April 1995, and a Director since 1987. He is the co-inventor of Ampligen', joined the company in 1978, and from 1987 to 1988, he served as the company's Chairman. Dr. Carter was a leading innovator in the development of human interferon for a variety of treatment indications including various viral diseases and cancer. In this context, he received the first FDA approval to initiate clinical trials on a beta interferon product manufactured in the US under his supervision. From 1985 to October 1988, Dr. Carter served as the company's Chief Executive Officer and Chief Scientist. He received his MD degree from Duke University and underwent his post-doctoral training at the National Institutes of Health and Johns Hopkins University. Dr. Carter also served as Professor of Neoplastic Diseases at Hahnemann Medical University, a position he held from 1980 to 1998. He also served as Director of Clinical Research for Hahnemann Medical University's Institute for Cancer and Blood Diseases, and as a Professor at Johns Hopkins School of Medicine and the State University of New York at Buffalo. He is a Board certified physician and author of more than 200 scientific articles, including the editing of various textbooks on anti-viral and immune therapy
 

 




 


 

PIPELINE.

Commercial Products

Country:  USA
PRODUCT NAME   CATEGORY   COMMERICAL STATUS
     
Alferon N Injection®   Genital HPV (condylomata acuminata)   Sales anticipated to resume upon successful pre-approval inspection and supplemental approval by FDA
 
Country:  Argentina
PRODUCT NAME   CATEGORY   COMMERICAL STATUS
     
Alferon N Injection®   Genital HPV (condylomata acuminata)   Approved. Launch pending manufacturing approval
     
Alferon N Injection®   Refractory to Recombinant IFN   Approved. Launch pending manufacturing approval
     
Rintatolimod (U.S. Tradename: Ampligen®)   Severe Cases of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)   Approved. Launch pending
 
Product Candidate   Country   Indication
Ampligen®   USA   CFS/ME
     
Ampligen®   USA   HIV
     
Ampligen®   USA   Metastatic Melanoma
     
Ampligen®   USA   Renal Cell Carcinoma
     
Ampligen®   European Union   Ebola Virus Disease
     
Alferon N Injection®   European Union   MERS
 
 

 





 

 

Cannabis Report
HEB
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
HEB News: Hemispherx to Distribute Second Lot of Ampligen® for use in Multiple Indications in Argentina, the United States and Europe 09/18/2018 08:30:00 AM
HEB News: Current Report Filing (8-k) 09/13/2018 04:17:39 PM
HEB News: Hemispherx Releases Recently Manufactured Ampligen for Pancreatic Cancer Early Access Program in the Netherlands to Fill Stoc... 08/28/2018 08:30:00 AM
HEB News: Hemispherx to Present at the 20th Annual Rodman & Renshaw Global Investment Conference 08/24/2018 08:30:00 AM
HEB News: Hemispherx Reports Six Months Ended June 30, 2018 Financial Results and Provides Business Update 08/15/2018 08:38:27 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#15523   9/18: HEB to Distribute Second Lot of Ampligen Saskey 09/18/18 09:41:03 AM
#15522   ===bor==== Looks like we may have a bull by oltimer 09/03/18 12:24:56 PM
#15521   The MACD showing selling for the 30 min borbash 09/02/18 05:11:22 PM
#15520   Insider and CFO Adam Pascale picked up his borbash 09/02/18 05:08:41 PM
#15519   encouraging PR's hopefully slow climb to 40 borbash 09/02/18 05:07:09 PM
#15518   ====bor==== Any good news and we will have double. oltimer 08/31/18 11:27:57 AM
#15517   Right-to-try' bill passes Congress borbash 08/31/18 10:39:03 AM
#15516   /15: Hemispherx Releases First 8,500 Vial Lot of borbash 08/31/18 10:37:20 AM
#15515   Close to cancer news in my opinion borbash 08/31/18 10:35:45 AM
#15514   Long here on technicals. Good luck borbash 08/31/18 10:34:38 AM
#15513   Not holding out hopes on a cure for Saskey 08/29/18 09:21:50 AM
#15512   ===Saskey=== Looks like it is doing pretty well. I oltimer 08/28/18 12:18:58 PM
#15511   8/28: HEB Releases Recently Manufactured Ampligen for Pancreatic Saskey 08/28/18 11:06:13 AM
#15510   Hey Stocks, I’m just as bewildered as you. momoney163 08/21/18 11:44:16 AM
#15509   I want to hear from people close to StocksInc 08/18/18 09:38:34 AM
#15508   One day they will find a cure Jumpinjackas 08/09/18 10:48:01 PM
#15507   Millions suffer from an invisible disease: My ME/CFS momoney163 08/08/18 11:29:40 AM
#15506   ====Sask======= Yes they just keep buying. I pick oltimer 07/27/18 10:37:59 AM
#15505   There it is again! Insider buying as per Saskey 07/27/18 09:45:31 AM
#15504   I don’t see it? Perhaps some more direction. Ultraz2 07/24/18 09:32:53 PM
#15503   Saskey Look above about the middle of page and oltimer 07/24/18 09:37:37 AM
#15502   Insider buying? Can somebody verify? I see insiders Saskey 07/24/18 09:27:36 AM
#15501   =====Ever body gone to sleep missing all of oltimer 07/23/18 07:37:05 PM
#15500   Where did everybody go? No post in 16 days===== oltimer 07/23/18 11:13:10 AM
#15499   Yes and it was around 8/1 if I cash4me2 07/07/18 12:20:55 AM
#15498   .30 is the pre split price?? Oy vey. momoney163 07/07/18 12:14:33 AM
#15497   This already had a reverse split and now cash4me2 07/06/18 11:35:11 PM
#15496   Airplane I meant. momoney163 06/28/18 06:08:05 PM
#15495   Lol I’m referencing the “.... and don’t call momoney163 06/28/18 06:05:33 PM
#15494   mom=== Mom is short for momoney163==You should be smart oltimer 06/28/18 04:19:49 PM
#15493   .... and don’t call me mom, I’m not momoney163 06/28/18 01:53:34 PM
#15492   Same bs, I’m out. GL momoney163 06/27/18 11:54:35 AM
#15491   I’ll bet UNMC has never heard of Heb. momoney163 06/25/18 02:45:28 PM
#15490   I’m hearing a buyout at .30 though. momoney163 06/25/18 01:26:48 PM
#15489   I’m hearing .33 soon. Hahaha (yeah right.) momoney163 06/25/18 11:54:04 AM
#15488   This thing is getting ready shake rattle and oltimer 06/19/18 04:45:29 PM
#15487   Add to watchlist oltimer 06/19/18 04:35:11 PM
#15486   Volume seems too inconsistent if this is an momoney163 06/19/18 01:39:06 PM
#15485   mom You never know about a .30 cent stock. oltimer 06/19/18 01:25:40 PM
#15484   I don’t doubt them or you. I’m sure momoney163 06/19/18 11:48:50 AM
#15483   mom All i know they have a lot oltimer 06/18/18 07:59:04 PM
#15482   Waiting on that $10,- HelloKitty8 06/18/18 07:40:28 PM
#15481   What the hell is wrong with this stock? momoney163 06/18/18 02:56:54 PM
#15480   6/15: Hemispherx Releases First 8,500 Vial Lot of Saskey 06/18/18 09:11:53 AM
#15479   NEWS OUT===== oltimer 06/15/18 11:22:05 AM
#15478   ..... to .31 is more like it. momoney163 06/14/18 03:34:03 PM
#15477   Who mentioned NWBO? God I hope not, then momoney163 06/07/18 11:28:27 AM
#15476   I'm in. Looking good :-) Go HEB go! Saskey 06/06/18 11:34:38 AM
#15475   encouraging PR's hopefully slow climb to 40 shurtha2000 06/06/18 12:40:09 AM
#15474   Roswell?? Sounds like they’ll be experimenting with aliens. momoney163 06/01/18 12:58:40 PM
PostSubject